Business / Finance

RSS

Medworxx announces expansion into the U.S.

On the heels of a year marking 36% growth in hospital beds served, Medworxx Inc., a leader in clinical patient flow solutions, announced today its expansion into the USA.

15 Feb 2012

Teva fourth quarter net revenues increase 28% to $5.7 billion

Teva Pharmaceutical Industries Ltd. today reported results for the quarter and year ended December 31, 2011.

15 Feb 2012

Microsoft, GE announce several developments for planned joint venture

General Electric Co. (GE), through its healthcare IT business, and Microsoft Corp. today announced several developments for their planned 50-50 joint venture, including the intention to demonstrate future product capabilities at HIMSS12, the year's largest healthcare IT trade show, later this month.

14 Feb 2012

Alnylam commences underwritten public offering of 7,000,000 shares of common stock

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced that it has commenced an underwritten public offering of 7,000,000 shares of its common stock. All of these shares are being sold by Alnylam.

14 Feb 2012

Bristol-Myers Squibb acquires Inhibitex

Bristol-Myers Squibb Company announced today the successful completion of the tender offer by Bristol-Myers Squibb Company for all of the outstanding shares of common stock of Inhibitex, Inc. at a purchase price of $26.00 per share.

13 Feb 2012

InComm announces acquisition of Medagate

InComm, a leading prepaid product and transaction services company, announced today that it has acquired Medagate Corporation, the company that powers OTCNetwork, the only national closed loop over-the-counter (OTC) healthcare benefits payments platform.

13 Feb 2012

Cardium to raise $5.0 million in registered direct offering

Cardium Therapeutics today announced that it has entered into definitive agreements with three institutional and accredited investors to sell an aggregate of 17,857,143 shares of its common stock in a registered direct offering for gross proceeds of approximately $5.0 million, before deducting placement agent's fees and estimated offering expenses.

13 Feb 2012

Bode announces acquisition of Chromosomal Laboratories

Bode Technology, a leading provider of forensic DNA services, announced today the acquisition of Chromosomal Laboratories, Inc., a leading provider of DNA testing for immigration and private paternity.

13 Feb 2012

Bristol-Myers completes tender offer for Inhibitex

13 Feb 2012

Most pharmas concerned over ability to meet EMA EVMPD deadline

Polling conducted by Virtify, Inc. revealed that most pharmaceutical companies are concerned about their ability to comply with the requirement to submit additional pharmacovigilance data to the EMA EudraVigilance Medicinal Product Dictionary (EVMPD) in advance of the July 2, 2012 deadline.

13 Feb 2012

Ocean Nutrition Canada purchases Alicorp fish oil refining plant

Ocean Nutrition Canada (ONC) the world's largest Omega-3 ingredient supplier, today announced its acquisition of a fish oil refining plant in Piura, Peru. With the purchase of the plant, ONC will now offer its customers a completely integrated supply chain, from primary processing through to finished ingredient.

13 Feb 2012

Linden to acquire SeraCare

SeraCare Life Sciences, Inc., a global life sciences company providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics, today announced that it has entered into a definitive agreement to be acquired by an affiliate of Linden Capital Partners, a Chicago-based private equity firm that focuses on middle market leveraged buyout investments in the healthcare and life science industries.

13 Feb 2012